Babler Martin

Director at NGNE; President, CEO at Principia Biopharma Inc.

Sold, on record
$3.4M
Dollars the filings state
Form 4 sales
3
Latest Jun 23, 2020
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Principia Biopharma Inc.Unusual
    Dec 18, 2019 2019

    Sold 29,500 shares at $53.07 ($1.6M)

    Babler Martin, President, CEO

    Sold 65.3% of holdings ($2.4M position)15,696 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Principia Biopharma Inc.Unusual
    Mar 3, 2020 +76 days

    Sold 15,000 shares at $63.47 ($952k)

    Babler Martin, President, CEO

    Sold 27.7% of holdings ($3.4M position)39,179 shares leftFiling

  3. 3 Form 4 sale Principia Biopharma Inc.Unusual
    Jun 23, 2020 +112 days

    Sold 15,000 shares at $61.86 ($928k)

    Babler Martin, President, CEO

    Sold 94.9% of holdings ($978k position)810 shares leftFiling

  4. 4 Form 144 notice NGNENotice
    Mar 7, 2024 +1353 days

    Filed to sell 2,500 shares ($98k)

    Babler Martin, Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Babler Martin
Source
Mar 7, 2024Mar 7, 2024NGNEDirectorForm 144 notice2,500$98kNoticeSEC
Jun 23, 2020Jun 25, 2020Principia Biopharma Inc.President, CEOForm 4 sale15,000$928k94.9%UnusualSEC
Mar 3, 2020Mar 5, 2020Principia Biopharma Inc.President, CEOForm 4 sale15,000$952k27.7%UnusualSEC
Dec 18, 2019Dec 19, 2019Principia Biopharma Inc.President, CEOForm 4 sale29,500$1.6M65.3%UnusualSEC